Kreisman H, Wolkove N, Finkelstein H S, Cohen C, Margolese R, Frank H
Thorax. 1983 Mar;38(3):175-9. doi: 10.1136/thx.38.3.175.
Review of the case notes of 660 patients with a diagnosis of breast cancer during a five-year period showed that in 119 cases there had been thoracic metastases. These were recorded as pleural or extrapleural metastases (79 patients), mediastinal tumour (46 patients), lymphangitic carcinoma (41 patients), pulmonary nodules (34 patients), and solitary pulmonary nodule (nine patients). Endobronchial metastases were present in seven patients and multiple pulmonary tumour emboli in two. The thorax was often the initial site of tumour recurrence. Most of these recurrences were present in several locations (intrathoracic or both intrathoracic and extrathoracic) simultaneously, facilitating the clinical diagnosis of metastatic breast cancer. Histopathological confirmation of metastasis was mandatory for the 10 patients who had a solitary intrathoracic abnormality without evidence of disease elsewhere. The median survival after diagnosis and treatment of a solitary thoracic metastasis was 42+ months and three of 10 patients are currently in remission (at 44, 87, and 121 months). The small tumour burden and early diagnosis giving lead time may explain the long survival in this group of patients.
对660例在五年期间被诊断为乳腺癌的患者病历进行回顾显示,119例存在胸内转移。这些转移被记录为胸膜或胸膜外转移(79例患者)、纵隔肿瘤(46例患者)、淋巴管癌(41例患者)、肺结节(34例患者)和孤立性肺结节(9例患者)。7例患者存在支气管内转移,2例存在多发性肺肿瘤栓子。胸部常常是肿瘤复发的初始部位。这些复发大多同时出现在多个部位(胸内或胸内及胸外均有),有助于转移性乳腺癌的临床诊断。对于10例胸内存在孤立性异常且其他部位无疾病证据的患者,转移的组织病理学确认是必需的。孤立性胸内转移诊断和治疗后的中位生存期为42 + 个月,10例患者中有3例目前处于缓解状态(分别为44、87和121个月)。肿瘤负荷小以及早期诊断带来的时间优势可能解释了这组患者的长期生存。